New Philanthropy Prize Gives Scientists Capital Control
The $5.5 million initiative shifts donation decisions to Nobel laureates, changing the funding model for research institutions.
Updated on Oct. 24, 2026 in Philanthropy
Live Poll
Do you believe scientists are better equipped than donors to determine where charity is most effective?
The Herbert Wertheim Trust for Humanity has launched the Wertheim Laureate Prize, a $5.5 million charitable program. The initiative empowers Nobel laureates in medicine to direct donations to universities and medical schools while participating in academic lectures.
Why it matters
The program reflects a trend of high-net-worth philanthropists delegating capital allocation decisions to subject-matter experts. For operators in the nonprofit and education sectors, this highlights a new competitive landscape for research and institutional funding.
The initiative allocates $5.5 million in total grants over a three-year cycle, including $1 million directed by each of the three 2026 laureates. An additional 10 scientists honored between 2021 and 2025 will each manage $250,000 for their chosen causes.
The players
Herbert Wertheim
An 87-year-old entrepreneur and founder of the optical technology company Brain Power Inc.
Scripps Research
A nonprofit biomedical research facility based in La Jolla, California.
Herbert Wertheim Trust for Humanity
A private philanthropic organization established to distribute charitable grants to scientific and academic causes.
The details
The prize shifts philanthropic control from the donor to the scientists themselves, who are tasked with identifying where capital generates the most impact. Beyond the financial contributions, the laureates will engage in on-campus lectures and visits at academic institutions. The Trust currently supports recipients in physiology or medicine but plans to expand the initiative to include physics, chemistry, and economic sciences.
Timeline
2021: Herbert Wertheim joined the Scripps Research board of directors.
2021-2025: Period in which 10 participating scientists received their Nobel Prizes.
October 2026: The Wertheim Laureate Prize was officially launched.
2027: Expected start for the first rounds of scientific lectures and campus visits.
Market Landscape
The program marks a departure from traditional institutional grant models by decentralizing the capital allocation process. It follows a growing trend of private trusts delegating significant distribution authority to specific research experts.
Educational institutions should monitor the Trust's selection process for future expansion into chemistry and physics. Organizations in the research sector should note the emphasis on expert-led donation directing as a potential benchmark for private grant competition.
The takeaway
Philanthropy is increasingly moving toward decentralized models where the donor acts as a facilitator for expert-led impact. Operators should track the 2027 rollout of the lecture series to identify how participating universities leverage these laureates for competitive academic positioning.
What happens next
The trust expects to launch the first lectures and university visits in 2027, marking the beginning of the program's active engagement phase.
Further reading
For broader analysis on how private capital supports research, read the latest coverage in Philanthropy.
Live Poll
Do you believe scientists are better equipped than donors to determine where charity is most effective?
